Revenue

With key hires from the semiconductor world and AWS, SambaNova isn't just growing. It's making a high-stakes bet on premium inference and autonomous AI.

Healthcare Triangle secures $3.6M in complex convertible debt to fuel its AI ambitions. We unpack the high-stakes financing and what it means for the future.

Dapper Labs moves NBA Top Shot Moments to decentralized storage. This isn't just a tech upgrade; it's a strategic move to reclaim trust in a fragile market.

An AI platform that translates emotion into fragrance choice just won a top award. It’s more than innovation; it’s a strategic disruption of a legacy industry.

EXL's new Gold Tier status with Databricks isn't just a partnership upgrade; it's a strategic move to solve AI's biggest business problem: data governance.

Shake Shack appoints retail veteran Christiane Pendarvis, signaling a strategic pivot to digital commerce and omnichannel growth to fuel its next expansion phase.

A Solana memecoin raised nearly $100k for breast cancer prevention, revealing a potentially resilient new model for creating sustainable social impact.

Jurupa Community Services District's national recognition isn't just an award; it's a strategic model for how investing in people drives superior service.

The Anne Frank Center USA is taking Holocaust education to TikTok and Instagram, battling misinformation where it thrives. Can short-form video win this fight?

As Dead by Daylight celebrates 10 years, we look past the sold-out fan fest to the strategy that turned a Montreal studio into a global economic force.

Echo IQ partners with Mayo Clinic to test its AI for cardiac risk in cancer patients, a key move for validation in the burgeoning cardio-oncology sector.

A new partnership between isolved and PosterElite aims to automate labor law compliance, a complex and costly administrative headache for employers in the modern era.

In markets like Paradise Valley, where location is king, a new trend emerges. High-value homeowners are investing heavily to elevate, not abandon, their irreplaceable properties.

A new book signals a major shift in the veterinary industry, where AI-driven strategy is becoming the key to survival and growth in a competitive market.

AFX's new Head of Growth, a veteran of HSBC and DBS, signals a bigger trend: DeFi is building a new financial system with Wall Street's old rulebook.

As Xtract One woos investors in Vegas, its AI security tech promises safety without sacrificing freedom. But can it scale its vision of a frictionless world?

QXO clears a major financial hurdle in its $17B TopBuild acquisition by restructuring debt, signaling a new era of consolidation in the building materials sector.

Kymera Therapeutics reports promising data for KT-621, a first-in-class oral drug that removes a key inflammatory protein, not just block it.

MBX Biosciences' new one-year data for canvuparatide isn't just a clinical win; it's a calculated move to dominate a billion-dollar market left vacant.

Jazz Pharma's lung cancer drug Zepzelca fails a key trial, raising regulatory questions. Yet its strength in another setting reveals a complex drug development system.